Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bourg-en-Bresse
Clinical trial register · France

Clinical Trials in Bourg-en-Bresse, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9729 matching records held by the registry are in this view. Synced 14 Nov 2026, 03:18 UTC
9729
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1030
Lead sponsors
across recruiting studies
Top sites
Paris 2848 Lyon 1397 Bordeaux 1393 Marseille 1290 Lille 1276
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hospices Civils de Lyon5 Centre Leon Berard3 UNICANCER2 University Hospital, Tours2 Assistance Publique - Hôpitaux de Paris2 Centre Francois Baclesse1 University Hospital, Clermont-Ferrand1 Centre Hospitalier Régional Metz-Thionville1 Olema Pharmaceuticals, Inc.1 Janssen Research & Development, LLC1 Eagle Pharmaceuticals, Inc.1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 Ipsen1 Centre Hospitalier Emile Roux1 Inotrem1 GBG Forschungs GmbH1 AstraZeneca1 F2D Medical1 DIAMPARK1 Poitiers University Hospital1 University Hospital, Brest1 Biotronik AG1 GCS Ramsay Santé pour l'Enseignement et la Recherche1 Societe Francaise de Rhumatologie1
Site location
Paris2848 Lyon1397 Bordeaux1393 Marseille1290 Lille1276 Montpellier1014 Toulouse1011 Nantes912 Dijon813 Angers773 Nice771 Clermont-Ferrand750 Caen727 Brest726 Strasbourg674 Amiens622 Villejuif570 Créteil559 Besançon553 Bron551 Rennes537 Grenoble514 Rouen388 Poitiers349 Pierre-Bénite344 Show all 805
All 805 locations
Target enrolment
to

Trials with a site in Bourg-en-Bresse

33 of 9729 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Remote Ischemic Postconditioning in Septic Shock
NCT07273942Adult Patients With Septic Shock Admitted in Intensive Care Unit
Hospices Civils de Lyon
Not applicable
720
Besançon, Bourg-en-Bresse, Clermont-Ferrand, Créteil, Dijon, La Tronche, Le Kremlin-Bicêtre, Lille
2027-01
Not yet open
Early Corticosteroids in Severe Influenza Pneumonia
NCT07786662Severe Influenza, Intensive Care (ICU), Reanimation, Infectious Diseases
Centre Hospitalier Régional Metz-Thionville
Phase 3
544
Argenteuil, Bobigny, Bourg-en-Bresse, Caen, Cannes, Cherbourg, Colombes, Créteil
2026-09
Not yet open
Centre Leon Berard
Phase 1/2
50
Bourg-en-Bresse, Clermont-Ferrand, Grenoble, Lille, Lyon, Marseille, Saint-Priest-en-Jarez, Toulouse
2026-09
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Auxerre, Avignon, Bayonne, Beauvais, Blois, Bobigny, Bordeaux, Bourg-en-Bresse
2026-06-26
Not yet open
Inhaled Amikacin Versus Placebo in Patients With Ventilator-associated Tracheobronchitis
NCT07665788Ventilator-Associated Pneumonia, Ventilator-Associated Tracheobronchitis
University Hospital, Tours
Phase 3
250
Angers, Argenteuil, Blois, Bourg-en-Bresse, Créteil, Dieppe, Dijon, Dreux
2026-06-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
1,200
Aix-en-Provence, Bordeaux, Bourg-en-Bresse, Brest, Caen, Dieppe, Fréjus, Garches
2025-11-05
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
1,084
Amiens, Angers, Argenteuil, Bobigny, Bourg-en-Bresse, Colombes, Corbeil-Essonnes, Créteil
2025-08-19
Not yet open
Non-medicinal Technique and Dyspnea in Weaning Patients
NCT06926231Difficult Mechanical Ventilation Weaning, Spontaneous Breathing Trial, Dyspnea
Hospices Civils de Lyon
Not applicable
82
Bourg-en-Bresse, Clermont-Ferrand, La Tronche, Lyon, Pierre-Bénite
2025-06-01
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
100
Bourg-en-Bresse
2024-12-31
Not yet open
Performance Study of the Thermodiag Solution for Body Temperature Measurement
NCT06703931Temperature Change, Body, Emergency Department Visit
F2D Medical
Not applicable
60
Bourg-en-Bresse, Charleville-Mézières, Trappes, Trévenans
2024-11-26
Recruiting
Centre Leon Berard
Not applicable
100
Angers, Bourg-en-Bresse, Dijon, Grenoble, Lyon, Marseille, Nice, Saint-Herblain
2024-11-15
Not yet open
DIAMPARK
Not applicable
300
Angers, Bourg-en-Bresse, Caen, Clamart, Le Puy-en-Velay, Montpellier, Nice, Troyes
2024-07-01
Recruiting
Weaning Protocol for High-flow Nasal Oxygen Therapy in Intensive Care
NCT06104956Acute Hypoxemic Respiratory Failure, High-flow Nasal Oxygen Therapy
University Hospital, Tours
Not applicable
370
Blois, Bourg-en-Bresse, Bourges, Caen, Chartres, Cholet, Dax, Le Mans
2024-02-17
Recruiting
Hospices Civils de Lyon
Not applicable
538
Angers, Bourg-en-Bresse, Clermont-Ferrand, Grenoble, Lyon, Toulouse, Villefranche-sur-Saône
2024-01-19
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Exemestane·Anastrozole·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
510
Bourg-en-Bresse, Besançon, Nantes, Compiègne, Clermont-Ferrand, Le Mans, Villejuif, Caen
2023-11-16
Active, closed
Ipsen
Observational
113
Bagnères-de-Bigorre, Bar-le-Duc, Besançon, Bordeaux, Bourg-en-Bresse, Brest, Corbie, Dax
2023-11-16
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Amiens, Antony, Arras, Avignon, Bayonne, Besançon, Bordeaux, Bourg-en-Bresse
2023-10-24
Recruiting
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
NCT05639413Metastatic Colorectal Cancer, BRAF V600E Mutation Positive
UNICANCER
Not applicable
400
Avignon, Bayeux, Beauvais, Bordeaux, Bourg-en-Bresse, Cahors, Calais, Caluire-et-Cuire
2023-07-24
Active, closed
Eagle Pharmaceuticals, Inc.
Phase 2
276
La Roche-sur-Yon, Angers, Argenteuil, Belfort, Bourg-en-Bresse, Dieppe, Dijon, Garches
2023-07-22
Recruiting
Hospices Civils de Lyon
Observational
2,671
Bourg-en-Bresse, Lyon, Metz-Tessy, Pierre-Bénite, Villefranche-sur-Saône
2023-05-01
Recruiting
AstraZeneca
Phase 3
4,300
Angers, Argenteuil, Avignon, Bordeaux, Bourg-en-Bresse, Caen, Cholet, Clermont-Ferrand
2023-03-31
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Aix-en-Provence, Besançon, Bordeaux, Bourg-en-Bresse, Brest, Bron, Chartres, Clermont-Ferrand
2023-02-15
Recruiting
Poitiers University Hospital
Not applicable
670
Angers, Argenteuil, Aurillac, Avignon, Belfort, Bordeaux, Bourg-en-Bresse, Brest
2023-02-02
Active, closed
University Hospital, Brest
Observational
160
Angers, Bordeaux, Bourg-en-Bresse, Brest, Caen, Lille, Limoges, Marseille
2022-05-12
Recruiting
Centre Hospitalier Emile Roux
Not applicable
300
Bourg-en-Bresse, Caluire-et-Cuire, Carcassonne, Contamine-sur-Arve, Le Puy-en-Velay, Mantes-la-Jolie, Montélimar, Saint-Priest-en-Jarez
2021-08-09
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
DrugsXeloda·Sacituzumab Govitecan·Paraplatin·Capecitabine
GBG Forschungs GmbH
Phase 3
1,332
Angers, Avignon, Bordeaux, Bourg-en-Bresse, Caen, Clermont-Ferrand, Dijon, Lille
2020-10-28
Active, closed
BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry
NCT04555174Coronary Artery Disease, Myocardial Ischemia
Biotronik AG
Observational
872
Agen, Aix-en-Provence, Antibes, Bastia, Bayonne, Bourg-en-Bresse, Caen, Clermont-Ferrand
2020-09-25
Recruiting
Brain-injured Patients Extubation Readiness Study
NCT04080440Mechanical Ventilator Weaning, Acute Brain Injury, Altered Level of Consciousness, Mechanical Ventilation
University Hospital, Clermont-Ferrand
Not applicable
660
Angers, Bordeaux, Bourg-en-Bresse, Caen, Clermont-Ferrand, Grenoble, La Réunion, Lille
2020-02-09
Active, closed
Inotrem
Phase 2
355
Angers, Argenteuil, Béthune, Bourg-en-Bresse, Dijon, La Roche-sur-Yon, Le Kremlin-Bicêtre, Le Mans
2019-11-13
Active, closed
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
NCT04602091Rheumatoid Arthritis, Inflammatory Rheumatism, Psoriatic Arthritis, Spondyloarthritis
Societe Francaise de Rhumatologie
Observational
2,300
Antibes, Bayonne, Belfort, Besançon, Bobigny, Bordeaux, Bourg-en-Bresse, Brest
2019-10-08
Active, closed
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
NCT03418844Germ Cell Tumor, Sex Cord Stromal Tumor, Malignant Non-epithelial Ovarian Tumors
Centre Francois Baclesse
Not applicable
268
Paris, Angers, Besançon, Bordeaux, Bourg-en-Bresse, Caen, Clermont-Ferrand, Lyon
2018-05-07
Recruiting
Biological Bank for Atrial Fibrillation and Stroke
NCT03611816Stroke, Atrial Fibrillation
Hospices Civils de Lyon
Observational
1,000
Bourg-en-Bresse, Bron, Pierre-Bénite, Villeurbanne
2018-04-23
Recruiting
LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer
NCT02511288Carcinoma, Non-Small-Cell Lung
Centre Leon Berard
Observational
900
Annecy, Bourg-en-Bresse, Bron, Grenoble, Lyon, Saint-Priest-en-Jarez, Villefranche-sur-Saône
2015-07
Rows per page Showing 1–33 of 33
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-france/city/bourg-en-bresse

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,729 studies in total at the last sync on 14 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 33 of those studies with a site in Bourg-en-Bresse.

How many clinical trials are recruiting in Bourg-en-Bresse?

16 of the 33 studies on this page are recruiting new participants as of the 14 Nov 2026, 03:18 UTC sync. A further 7 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bourg-en-Bresse), 33 studies
PhaseStudiesRecruitingShare
Not applicable151045.5%
Observational8424.2%
Phase 37221.2%
Phase 2206.1%
Phase 1/2103%

Most active sponsors

Lead sponsors with the most studies (Bourg-en-Bresse)
Lead sponsorStudiesRecruiting
Hospices Civils de Lyon53
Centre Leon Berard32
Assistance Publique - Hôpitaux de Paris22
UNICANCER22
University Hospital, Tours21
AstraZeneca11
Biotronik AG10
Centre Francois Baclesse10
Centre Hospitalier Emile Roux11
Centre Hospitalier Régional Metz-Thionville10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.